Oral taurine supplementation prevents fructose-induced hypertension in rats

Heart and Vessels

Volumn 19, Issue 3, 2004, Pages 132-136

  Harada, Hisashi ^a   Tsujino, Takeshi ^a   Watari, Yasuhiro ^a   Nonaka, Hidemi ^a   Emoto, Noriaki ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fructose; Hyperinsulinemia; Intracellular calcium; Intracellular magnesium; Taurine

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM; CHOLESTEROL; CREATININE; DRINKING WATER; FRUCTOSE; GLUCOSE; LIPID; MAGNESIUM; POTASSIUM; SODIUM; TAURINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID METABOLISM; MAGNESIUM BLOOD LEVEL; MALE; METABOLIC PARAMETERS; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RAT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; BLOOD PRESSURE; CALCIUM; FRUCTOSE; HYPERTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

EID: 3042565141     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-003-0757-1     Document Type: Article

References (32)

1. Ferrannini E, Galvan AQ (t992) Hyperinsulinemia, insulin resistance, and blood pressure. Hypertens Res 15:67-75
2. Kaplan NM (1996) The deadly quartet and the insulin resistance syndrome: an historical overview. Hypertens Res 19(suppl I):S9-S11
3. Sechi LA (1999) Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens 17:1229-1237
4. Nara Y, Yamori Y, Lovenberg W (1978) Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol 27:2689-2692
5. Fujita T, Sato Y (1984) The antihypertensive effect of taurine in DOCA-salt rats. J Hypertens 2(suppl 3):563-565
6. Harada H, Kitazaki K, Tsujino T, Watari Y, Iwata S, Nonaka H, Hayashi T, Takeshita T, Morimoto K, Yokoyama M (2000) Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res 23:277-284
7. Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y (1996) Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303-313
8. Mizushima S, Nara Y, Sawamura M, Yamori Y (:1996) Effects of oral taurine supplementation on lipids and sympathetic nerve tone. In: Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M, Baba A (eds) Taurine 2: basic and clinical aspects. Plenum, New York, pp 615-622
9. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54-58
10. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M (2001) Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 104:1165-1170
11. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y on behalf of the WHO-Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24:453-457
12. Anuradha CV, Balakrishnan SD (1999) Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77:749-754
13. Hsieh ST, Saito K, Sano H, Yokoyama M (1992) Decreased platelet free magnesium with increased free calcium in mild essential hypertension. Hypertens Res 15:105-110
14. 2+ permeability in platelets of hypertensive rats. Hypertens Res 23:651-657
15. Resnick LM (1995) Ionic disturbances of calcium and magnesium metabolism in essential hypertension. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management, 2nd edn. Raven, New York, pp 1169-1191
16. Oshima T, Young EW (1995) Systemic and cellular calcium metabolism and hypertension. Semin Nephrol 15:496-503
17. Sunano S, Shimada T, Shimamura K, Moriyama K, Ichida S (1988) Extra- and intracellular calcium in vanadate-induced contraction of vascular smooth muscle. Heart Vessels 4:6-13
18. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA (1988) Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82:1848-1852
19. Levy J, Zemel MB, Sowers JR (1989) Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med 87(suppl 6A):7S-16S
20. + exchanger is associated with hyperinsulinemia in borderline hypertensive rats. Eur J Clin Invest 31:193-200
21. Bolli P, Erne P, Hulthén UL, Ritz R, Kiowski W, Ji BH, Bühler FR (1984) Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and β-adrenoreceptor blockade. J Cardiovasc Pharmacol 6:S996-S1001
22. Pollard TD (1975) Electron microscopy of synthetic myosin filaments: evidence for cross-bridge flexibility and copolymer formation. J Cell Biol 67:93-104
23. 2+-ATPase. Am J Hypertens 5:637-641
24. +-ATPase by insulin: why and how? Mol Cell Biochem 182:121-133
25. Kahn AM, Seidel CL, Allen JC, O'Neil RG, Shelat H, Song T (1993) Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22:735-742
26. Ishibashi K, Kageyama S, Sakurai T, Murakawa Y, Aihara K, Yokota K, Taniguchi I, Hashimoto Y, Fujita T, Tajima N (1997) Inhibitory effects of insulin on intracellular calcium and aggregatory response of platelets are impaired in hypertensive subjects with insulin resistance. Hypertens Res 20:225-231
27. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101-163
28. van der Schaaf MR, Joles JA, van Tol A, Koomans HA (1995) Long-term fructose versus corn starch feeding in the spontaneously hypertensive rat. Clin Sci (Lond) 88:719-725
29. Goodman HO, Shihabi ZK (1990) Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43:1-9
30. Paolisso G, Barbagallo M (1997) Hypertension, diabetes mellitus, and insulin resistance. The role of intracellular magnesium. Am J Hypertens 10:346-355
31. Balon TW, Jasman A, Scott S, Meehan WP, Rude RK, Nadler JL (1994) Dietary magnesium prevents fructose-induced insulin insensitivity in rats. Hypertension 23(pt 2):1036-1039
32. Suleiman MS (1994) New concepts in the cardioprotective action of magnesium and taurine during the calcium paradox and ischemia of the heart. Magnesium Res 7:295-312